|Bid||24.64 x 800|
|Ask||24.67 x 1000|
|Day's Range||24.50 - 24.68|
|52 Week Range||22.67 - 27.09|
|Beta (5Y Monthly)||1.07|
|PE Ratio (TTM)||1.95|
|Forward Dividend & Yield||1.44 (6.08%)|
|Ex-Dividend Date||Oct 31, 2022|
|1y Target Est||N/A|
J.P. Morgan today revealed its annual curation of "what's next": an enlightening collection of recommended books, experiences and cultural pursuits curated to inspire new perspectives as we turn the page to the new year. NextList2023 also features an innovative partnership focused on building social and professional equity for the next generation.
WASHINGTON, November 21, 2022--Dr. Cheryl Pegus, a nationally-recognized leader for her work to deliver affordable, high-quality care to millions of Americans, will join Morgan Health to support the organization’s strategic investments and broader efforts to improve the quality, affordability and equity of health care.
The securities fraud law firm of KlaymanToskes reports former San Francisco broker Edward L.